|Articles|January 2, 2015
FDA Approves Weight-Management Drug Saxenda
The drug Saxenda has been approved as a treatment option for chronic weight management for adults who are overweight or obese in addition to a reduced-calorie diet and exercise.
Advertisement
as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.
The FDA approved Saxenda
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obesity) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol (dyslipidemia).
The safety and effectiveness of Saxenda were evaluated in 3 clinical trials that included approximately 4800 obese and overweight patients with and without significant weight-related conditions. All patients received counseling regarding lifestyle modifications that consisted of a reduced-calorie diet and regular physical activity.
Read the press release:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Use of Collaborative Care Grows Rapidly, Uneven Medicaid Coverage Drives State Gaps
2
Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs
3
Intraarterial Alteplase After Thrombectomy May Improve Stroke Recovery: CHOICE2
4
Stroke Rates Are Rising in Younger Adults, as Older Populations See Declines: Emily R. Fisher, MD
5
